David Rosen is a healthcare entrepreneur who founded Serenium™, a revolutionary healthcare business that provides solutions for respiratory-related disorders. With over 20 years of clinically validated scalable solutions, Serenium targets over 500 million consumers in the US and China alone. Rosen believes early identification and intervention can help mitigate the resource expenditure of managing chronic disease while providing improved population health outcomes and lower overall cost.

Sleep disordered breathing (SDB) remains one of the most underdiagnosed and untreated medical conditions, often leading to chronic diseases. Rosen's innovative healthcare solutions aim to address this by providing early intervention, mitigating the health risks associated with respiratory illnesses.

Rosen studied at the Massachusetts Institute of Technology (MIT), and holds several positions at both Serenium™ and Serenium China. Before founding Serenium™, he was the founder and chairman of Serenium and MiaoVillage.com.